OMER vs PCVX Stock Comparison

PCVX currently leads OMER in this stock comparison, with AIQ scores of 66 vs 64. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 2 points
OMER
Healthcare
vs
PCVX
Healthcare
OMER
Omeros Corporation
Price
$17.49
Day move
-2.78%
AIQ Score
64/100
Best edge
Balanced
Sector
Healthcare
PCVX
Vaxcyte, Inc.
Leads
Price
$63.37
Day move
-2.04%
AIQ Score
66/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between OMER and PCVX?

PCVX leads the current stock comparison as Vaxcyte, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Omeros Corporation vs Vaxcyte, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

PCVX leads

PCVX leads by 2 AIQ points, primarily on Risk Resilience.

Fragile: 3 of 5 evidence groups support PCVX, and its current signal state is conflicted.

Evidence agreement: 3 of 5Comparison trend: Stable
OMER

Omeros Corporation

AIQ Score
64/100
AIQ Edge Score
7/10
PCVX

Vaxcyte, Inc.

Leads
AIQ Score
66/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors PCVX over OMER, 66 versus 64 as of Nov 15, 2026. PCVX's advantage is driven primarily by stronger risk resilience. PCVX also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor PCVX today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. PCVX lead: Stable — the AIQ differential has held near 2 points over 30 sessions.

Compare Omeros Corporation and Vaxcyte, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

OMER
+122.5%
PCVX
+153.4%

Price return comparison

Growth of $10,000, price only

OMER $22,252 · PCVX $25,338

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare OMER and PCVX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

OMER advantage
0
PCVX advantage
  • Risk Resilience33 vs 53
    PCVX +20
  • Momentum79 vs 81
    Even
  • Quality55 vs 54
    Even

3 of 5 evidence groups favor PCVX. PCVX’s edge is concentrated in risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

OMER0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • Low Volume Rally Warning — bearish, volume, short horizon (0.76x)
  • RSI Midline Rejection — bearish, momentum, short horizon
PCVX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-18.8%)
  • RSI Midline Rejection — bearish, momentum, short horizon

PCVX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — OMER and PCVX both carry a full feed there.

The central trade-off

PCVX (Vaxcyte, Inc.): the stronger current systematic profile, led by risk resilience.

OMER (Omeros Corporation): the counter-case, on technicals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

PCVX

PCVX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

OMER

OMER on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

PCVX

PCVX on Risk Resilience, by 20 points.

Analyst upside

PCVX

PCVX on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureOMERPCVXNote
Implied upside to target+25.8%+93%PCVX has more room
Target dispersion0%+4.1%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering311Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor PCVX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven64 vs 66
FundamentalsPCVXEPS growth -76.9% vs -1%; TTM ROE -25.8% vs -11.9%
ValuationNot coveredNot covered
TechnicalsOMERPrice vs 50-day -4.3% vs 1.8%; vs 200-day 27% vs 9.8%
Risk ResiliencePCVXRisk Resilience 33 vs 53
Analyst expectationsPCVXTarget upside 25.8% vs 93%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of OMER and PCVX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PCVX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

PCVX lead: Stable — the AIQ differential has held near 2 points over 30 sessions.

May 27OMER leads above the line · PCVX leads belowNov 13
Today
PCVX +2
64 vs 66
7 sessions ago
PCVX +1
65 vs 66
30 sessions ago
PCVX +1
66 vs 67
90 sessions ago
PCVX +5
58 vs 63

The lead changed hands 3 times in this window, most recently on Oct 12 when PCVX moved ahead of OMER.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

OMERConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only OMER

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.76x)
PCVXConflicted

5 bullish / 2 bearish / 1 neutral, conflicted

Only PCVX

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-18.8%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 4 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning, RSI Midline Rejection.

PCVX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

OMERNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.78%, AIQ 0 points).

PCVXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.04%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1OMER closes the Risk Resilience gap — currently 20 points behind, the largest single contributor to PCVX's edge.
  2. 2OMER's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3PCVX's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

PCVX leads on balance
MetricOMERPCVX
Revenue growth (YoY)188.4%0%
EPS growth (YoY)-76.9%-1%
Gross margin95.8%0%
Operating margin-189.5%0%
Return on equity (TTM)-25.8%-11.9%
Debt to equity-1.630.09

Performance

OMER leads 4 of 6 windows
MetricOMERPCVX
1 week (5 sessions)3.4%-0.8%
1 month (20 sessions)8%-0.4%
3 months (63 sessions)0.7%5.2%
6 months (126 sessions)42.8%21%
Year to date1.8%37.3%
1 year (252 sessions)153.8%37.5%

Technicals

OMER has the stronger structure
MetricOMERPCVX
RSI (14)47.949.5
ADX (14)12.226.6
Price vs 50-day-4.3%1.8%
Price vs 200-day27%9.8%
Volatility (1M, annualized)54.9%58.3%

Risk

PCVX is the more resilient
MetricOMERPCVX
Beta1.61.26
Sharpe ratio1.360.79
Sortino ratio3.041.39
Max drawdown-49.5%-28%
Current drawdown-16.9%-14.2%
Annualized volatility110.8%56.2%
Value at risk (95%)-6.7%-4.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, OMER or PCVX?

On the Algovestiq AIQ Score, PCVX is the stronger of the two as of Nov 15, 2026, scoring 66 against OMER's 64. The edge comes from risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is OMER or PCVX the better buy right now?

PCVX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.

Why does the AIQ Score favor PCVX over OMER?

The composite weights Quality, Value, Momentum and Risk Resilience. PCVX leads Risk Resilience by 20 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, OMER or PCVX?

Analyst price targets imply +25.8% upside for OMER and +93% for PCVX, so the Street currently favors PCVX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, OMER or PCVX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, OMER or PCVX?

OMER on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, OMER or PCVX?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, OMER or PCVX?

PCVX is the more resilient of the two, so the other name carries the higher downside risk. PCVX on Risk Resilience, by 20 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is OMER more profitable than PCVX?

PCVX leads on the comparable margin measures — gross margin 95.8% vs 0%; operating margin -189.5% vs 0%; ttm roe -25.8% vs -11.9%.

Is PCVX's lead over OMER getting stronger or weaker?

PCVX lead: Stable — the AIQ differential has held near 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-10-12, when PCVX moved ahead of OMER.

What would change the OMER vs PCVX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: OMER closes the Risk Resilience gap — currently 20 points behind, the largest single contributor to PCVX's edge; OMER's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; PCVX's conflicting signal state resolves bearish — it currently carries 5 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about OMER and PCVX?

OMER: 1 bullish / 3 bearish / 2 neutral, conflicted. PCVX: 5 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on OMER is Golden Cross Active (bullish, long horizon). On PCVX it is Golden Cross Active (bullish, long horizon).

Compare OMER and PCVX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.